Practice
Featured experience
Bristol Myers Squibb €5 billion notes offering
We advised the underwriters on Bristol Myers Squibb Ireland’s inaugural euro issuance
BETA Technologies $1 billion IPO
The shares are listed on the New York Stock Exchange
Vistra $2 billion secured notes offering
The investment-grade notes are due 2028, 2030 and 2035
American Industrial Partners $1.5 billion acquisition of Global Cellulose Fibers
We are advising American Industrial Partners on the transaction
Schlumberger $500 million notes offering
Davis Polk advised the representatives of the underwriters on an SEC-registered offering by Schlumberger Finance…
Murray Energy restructuring consummated
Davis Polk advised an ad hoc group of lenders (the “Ad Hoc Group”) to Murray Energy Corporation (together with certain of…
UMB Financial $200 million notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering by UMB…
PDC Energy $150 million notes offering
Davis Polk advised the representative of the underwriters in connection with a registered offering of $150 million aggregate…
Gilead Sciences $21 billion acquisition of Immunomedics
Davis Polk is advising Gilead Sciences, Inc. in its acquisition of Immunomedics, Inc. for $88.00 per share in cash. The…
Valero Energy $2.5 billion senior notes offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by Valero Energy Corporation of $2.5…
Emerson $1.6 billion acquisition of Open Systems International
Davis Polk is advising Emerson Electric Co. on its $1.6 billion acquisition of Open Systems International, Inc.
Emerson,…
Pike $500 million notes offering and $396 million credit facilities
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering of…
PPG $100 million notes offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a…
Eli Lilly $1.1 billion notes offering
Davis Polk advised the joint book-running managers in connection with a registered offering by Eli Lilly and Company of $1.1…